Abstracts

Performance of the Geenius HIV-1/HIV-2 Assay in the CDC HIV Testing Algorithm

Background: CDC recently released new guidelines for laboratory diagnosis of HIV infection in the United States (the “CDC algorithm”), which recommends use of an assay that differentiates HIV-1 from HIV-2 after a reactive HIV-1/HIV-2 screening test. Currently only the Multispot HIV-1/HIV-2 differentiation test (MS) is FDA-approved for this use. A new test, the Geenius HIV-1/HIV-2…

Estimation of HIV Incidence in a High-HIV-Prevalence Setting, South Nyanza, Kenya, 2012

Background: Tests for recent infection (TRI) use immunological markers to distinguish recent from chronic HIV infection, providing the ability to estimate HIV incidence and evaluate HIV prevention interventions. Several candidate TRIs, including the Limiting Antigen Avidity Enzyme Immunoassay (LAg) and Bio-Rad Avidity Enzyme Immunoassay (Bio-Rad) are being validated for field performance. We evaluated the performance…

Accuracy of POC CD4 testing using microtube capillary sampling in Botswana households

Background: Point of care (POC) CD4 cell count can reduce the time to eligibility assessment for antiretroviral treatment and improve linkage to care. In a village household setting in Botswana, we evaluated the performance of field POC CD4 testing versus conventional laboratory-based flow cytometry. Methods: Capillary blood was collected by finger-prick into EDTA microtubes. Venous…